IL116153A - Antithrombotic formulation and process for its manufacturing - Google Patents

Antithrombotic formulation and process for its manufacturing

Info

Publication number
IL116153A
IL116153A IL11615395A IL11615395A IL116153A IL 116153 A IL116153 A IL 116153A IL 11615395 A IL11615395 A IL 11615395A IL 11615395 A IL11615395 A IL 11615395A IL 116153 A IL116153 A IL 116153A
Authority
IL
Israel
Prior art keywords
manufacturing
antithrombotic
formulation
antithrombotic formulation
Prior art date
Application number
IL11615395A
Other languages
English (en)
Other versions
IL116153A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL116153A0 publication Critical patent/IL116153A0/xx
Publication of IL116153A publication Critical patent/IL116153A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
IL11615395A 1994-12-02 1995-11-27 Antithrombotic formulation and process for its manufacturing IL116153A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9404196A SE9404196D0 (sv) 1994-12-02 1994-12-02 New antithrombotic formulation

Publications (2)

Publication Number Publication Date
IL116153A0 IL116153A0 (en) 1996-01-31
IL116153A true IL116153A (en) 1999-11-30

Family

ID=20396207

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11615395A IL116153A (en) 1994-12-02 1995-11-27 Antithrombotic formulation and process for its manufacturing

Country Status (27)

Country Link
US (1) US5795896A (no)
EP (1) EP0799052B1 (no)
JP (1) JPH10513438A (no)
CN (1) CN1168635A (no)
AR (1) AR002254A1 (no)
AT (1) ATE208628T1 (no)
AU (1) AU689994B2 (no)
BR (1) BR9509853A (no)
CA (1) CA2206459A1 (no)
CZ (1) CZ147097A3 (no)
DE (1) DE69523943T2 (no)
DK (1) DK0799052T3 (no)
EE (1) EE03338B1 (no)
ES (1) ES2168395T3 (no)
FI (1) FI972332A0 (no)
HU (1) HU216631B (no)
IL (1) IL116153A (no)
IS (1) IS4483A (no)
NO (1) NO972475D0 (no)
NZ (1) NZ297118A (no)
PL (1) PL320692A1 (no)
PT (1) PT799052E (no)
SE (1) SE9404196D0 (no)
SK (1) SK61797A3 (no)
TR (1) TR199501517A2 (no)
WO (1) WO1996016671A1 (no)
ZA (1) ZA9510242B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6984627B1 (en) * 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
AR005245A1 (es) * 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
GB9526273D0 (en) * 1995-12-21 1996-02-21 Astra Ab New prodrugs
SE9602145D0 (sv) * 1996-05-31 1996-05-31 Astra Ab New improved formulation for treatment of thromboembolism
US6423334B1 (en) * 1997-10-01 2002-07-23 Elan Corporation, Plc Composition and method for enhancing transport across gastrointestinal tract cell layers
AR023510A1 (es) * 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
AR023819A1 (es) * 1999-05-03 2002-09-04 Astrazeneca Ab FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
EP2591806A1 (en) 2001-06-14 2013-05-15 Otsuka Pharmaceutical Co., Ltd. Medicinal composition
SE0103590D0 (sv) * 2001-10-26 2001-10-26 Astrazeneca Ab New Combination
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
RU2354647C2 (ru) 2007-06-28 2009-05-10 Общество С Ограниченной Ответственностью "Бионика" Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
EP2271347B1 (en) * 2008-03-28 2016-05-11 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
US8440631B2 (en) * 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
US20100215730A1 (en) * 2009-02-20 2010-08-26 Intrepid Therapeutics, Inc. Compositions for Nasal Administration of Phenothiazines
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
CA2781529C (en) * 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
EP2720699B1 (en) 2011-06-14 2018-05-16 Hale Biopharma Ventures, Llc Administration of benzodiazepine
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
US4568636A (en) * 1981-03-25 1986-02-04 Pentapharm Ag Tripeptide derivatives
US4395401A (en) * 1981-09-09 1983-07-26 Smithkline Beckman Corporation Renally active dipeptides
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
AU600226B2 (en) * 1985-02-04 1990-08-09 Merrell Pharmaceuticals Inc. Novel peptidase inhibitors
DE3505555A1 (de) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
DE3606480A1 (de) * 1986-02-28 1987-09-03 Behringwerke Ag Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (en) * 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV protease inhibitors
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
US5053392A (en) * 1989-12-01 1991-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
US5037819A (en) * 1990-06-04 1991-08-06 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5110812A (en) * 1990-06-04 1992-05-05 Bristol-Myers Squibb Co. Azetidin-2-one derivatives as serine protease inhibitors
TW201303B (no) * 1990-07-05 1993-03-01 Hoffmann La Roche
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
GB9019558D0 (en) * 1990-09-07 1990-10-24 Szelke Michael Enzyme inhibitors
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
EP0511347A1 (de) * 1990-11-15 1992-11-04 Pentapharm A.G. Meta-substituierte phenylalanin-derivate
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
NZ245039A (en) * 1991-11-12 1994-12-22 Lilly Co Eli N-phenylalanyl and n-phenylglycyl derivatives of the dipeptide of l-azetidine-2-carboxylic acid and l-arginine aldehyde; anti-blood clotting compositions
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives

Also Published As

Publication number Publication date
JPH10513438A (ja) 1998-12-22
PL320692A1 (en) 1997-10-27
DK0799052T3 (da) 2002-02-25
NO972475L (no) 1997-05-30
DE69523943D1 (de) 2001-12-20
SE9404196D0 (sv) 1994-12-02
AR002254A1 (es) 1998-03-11
HU216631B (hu) 1999-07-28
EP0799052A1 (en) 1997-10-08
IL116153A0 (en) 1996-01-31
HUT77655A (hu) 1998-07-28
DE69523943T2 (de) 2002-06-27
ATE208628T1 (de) 2001-11-15
FI972332A (fi) 1997-06-02
ZA9510242B (en) 1996-06-03
AU4191596A (en) 1996-06-19
SK61797A3 (en) 1998-03-04
MX9703975A (es) 1997-09-30
AU689994B2 (en) 1998-04-09
US5795896A (en) 1998-08-18
CZ147097A3 (cs) 1998-02-18
NZ297118A (en) 1998-12-23
CA2206459A1 (en) 1996-06-06
EE03338B1 (et) 2001-02-15
NO972475D0 (no) 1997-05-30
WO1996016671A1 (en) 1996-06-06
ES2168395T3 (es) 2002-06-16
CN1168635A (zh) 1997-12-24
BR9509853A (pt) 1997-12-30
PT799052E (pt) 2002-05-31
FI972332A0 (fi) 1997-06-02
TR199501517A2 (tr) 1996-07-21
IS4483A (is) 1997-05-16
EP0799052B1 (en) 2001-11-14

Similar Documents

Publication Publication Date Title
IL116153A (en) Antithrombotic formulation and process for its manufacturing
DK173391A (da) Boelgeenergi-kraftanlaeg
EP0708482A3 (en) BiCDMOS manufacturing technology and its structures
EP0705990A3 (en) Ball joint and method of manufacturing the same
GB9400972D0 (en) Process
AU2925495A (en) Washing process and composition
IL109656A0 (en) Process for the manufacture of androstane-17-carbothioates and androstane-17-carbothioates prepared thereby
GB9401969D0 (en) Process
HU9602105D0 (en) Intermediate and process for making
HU216713B (hu) Ciklusos acetálok és eljárás az előállításukra
HUT77565A (hu) Felmosó eszközök és eljárás a gyártásukhoz
GB9403133D0 (en) Process
GB9402604D0 (en) Microbiologial process
HU9502244D0 (en) 3-substituted 5-quinolinecarboxylicacid-derivative and process for its preparation
GB9401275D0 (en) Zeolite and manufacturing process
GB9402607D0 (en) Process
AU2047095A (en) Cleaning composition and cleaning process
HUP9601521A2 (en) Substituted quinoline-intermediates and process for preparation the same
HUP9601520A2 (en) Substituted quinoline-intermediates and process for preparation the same
ZA941780B (en) Wooden-like product manufacturing method and woodenlike product
GB9402622D0 (en) Novel method and formulation
GB9412064D0 (en) Bioadhesive starches and process for their preparation
GB9405872D0 (en) Biological process and formulation
GB9402213D0 (en) Process and compounds
GB9421478D0 (en) Process and compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees